The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state

Early Intervention in Psychiatry

Volumn 12, Issue 2, 2018, Pages 217-228

  Maurer, Kurt ^a   Zink, Mathias ^a   Rausch, Franziska ^a   Häfner, Heinz ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

depression; ERIraos; prediction of psychosis; psychosis risk screening; schizophrenia

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; INTERVIEW; MASS SCREENING; MENTAL HEALTH SERVICE; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SELF CONCEPT; TASK PERFORMANCE; URBAN AREA; ADOLESCENT; ADULT; CHILD; COMPLICATION; EARLY DIAGNOSIS; FEMALE; MALE; MIDDLE AGED; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PUBLICATION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; TRANSLATIONS; YOUNG ADULT;

EID: 84958786985     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12305     Document Type: Article

References (75)

1. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Aerzte, 4. Aufl. Leipzig: Barth, 1893.
2. Bleuler E. Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Stuttgart: Thieme, 1908.
3. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G, ed. Handbuch der Psychiatrie. Leipzig: Deuticke, 1911; 1–420.
4. Conrad K. Die beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Stuttgart: Thieme, 1958.
5. Janzarik W. Schizophrene Verläufe. Berlin, Heidelberg, New York: Springer, 1968.
6. Huber G. Psychiatrische Aspekte des Basisstörungskonzepts. In: Süllwold L, Huber G, eds. Schizophrene Basisstörungen. Berlin, Heidelberg, New York: Springer, 1986; 39–143.
7. Angermeyer MC, Kühn L. Gender differences in age at onset of schizophrenia. Eur Arch Psychiatr Neurol Sci 1988; 237: 351–364.
8. Häfner H, Riecher A, Maurer K et al. Ein Instrument zur retrospektiven Einschätzung des Erkrankungsbeginns bei Schizophrenie (Instrument for the retrospective assessment of the onset of schizophrenia – ‘IRAOS’) – Entwicklung und Ergebnisse –. Z Klin Psychol 1990; 19: 230–255.
9. Häfner H, Maurer K, Löffler W, Riecher-Rössler A. Schizophrenie und Lebensalter. Nervenarzt 1991a; 62: 536–548.
10. Häfner H, Riecher A, Maurer K et al. Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortschr Neurol Psychiatr 1991; 59: 343–360.
11. Häfner H, Maurer K, Löffler W et al. Onset and early course of schizophrenia. In: Häfner H, Gattaz WF, eds. Search for the Causes of Schizophrenia III. Berlin, Heidelberg: Springer, 1995; 43–66.
12. McGorry PD, McFarlane C, Patton GC et al. The prevalence of prodromal symptoms of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand 1995; 92: 241–249.
13. Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K. When and how does schizophrenia lead to social deficits? Eur Arch Psychiatry Clin Neurosci 1995; 246: 17–28.
14. Häfner H, Maurer K, Löffler W, Nowotny B. Der Frühverlauf der Schizophrenie. ZMP 1996; 5: 22–31.
15. Yung AR, Phillips LJ, Yuen HP et al. Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophr Res 2003; 60: 21–32.
16. Yung AR, Yuen HP, McGorry PD et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964–971.
17. Köhn D, Niedersteberg A, Wieneke A et al. Frühverlauf schizophrener Ersterkrankungen mit langer Dauer der unbehandelten Erkrankung – eine vergleichende Studie. Fortsch Neurol Psychiatr 2004; 72: 88–92. doi: 10.1055/s-2003-812509.
18. Schultze-Lutter F, Ruhrmann S. Früherkennung und Frühbehandlung von Psychosen. Bremen: Uni-Med Verlag, 2008.
19. Häfner H, Maurer K, Löffler W et al. Onset and prodromal phase as determinants of the course. In: Gattaz WF, Häfner H, eds. Search for the Causes of Schizophrenia, Vol. IV, Balance of the century. Darmstadt: Steinkopff, 1999; 35–58.
20. Häfner H, Maurer K. Prodromal symptoms and early detection of schizophrenia. In: Maj M, ed. Early Detection and Management of Mental Disorders. London: John Wiley, 2004; 1–49.
21. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67: 131–142.
22. Miller TJ, McGlashan TH, Rosen JL et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 159: 863–865.
23. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with ‘at-risk mental states’. Schizophr Res 2004; 71: 227–237.
24. Schultze-Lutter F, Ruhrmann S, Berning J et al. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 2010; 36: 182–191. doi: 10.1093/schbul/sbn072; [Epub 2008 Jun 25].
25. Nelson B, Yuen HP, Wood SJ et al. Long-term follow-up of a group at ultra high risk (‘prodromal’) for psychosis: the PACE 400 study. JAMA Psychiatry 2013; 70: 793–802.
26. Yung AR. The Comprehensive Assessment of At-Risk Mental States (CAARMS). Copyright, University of Melbourne 1996, 2000.
27. Yung A, Phillips L, Simmons MB et al. CAARMS Comprehensive Assessment of At Risk Mental States – Monthly Version, 2006.
28. Larsen TK, Johannessen JO, Opjordsmoen S. First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatry 1998; 172: 45–52.
29. McGlashan TH. Structured interview for prodromal symptoms (SIPS). Version for present prodromal symptoms (Version 2.2). Copyright TH McGlashan, PRIME Research Clinic, Yale School of Medicine, New Haven, CT, 2001.
30. Miller TJ, McGlashan TH, Woods SW et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999; 70: 273–287.
31. Miller TJ, McGlashan TH, Rosen JL et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703–715.
32. Häfner H, Riecher-Rössler A, Hambrecht M et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6: 209–223.
33. Häfner H, Löffler W, Maurer K, Riecher-Rössler A, Stein A. IRAOS – Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses. Göttingen: Hogrefe & Huber, 2003.
34. Grosso L, Maurer K, Thibaut F. Prise en charge précoce des psychoses: le temps des pratiques. PSN 2005; III (Suppl. 1): 2–7.
35. Barajas A, Ochoa S, Farreny A et al. Assessment of prodromal symptoms in incipient psychotic disorders: reliability and validity measures of the Early Recognition Inventory-Spanish Version (ERIraos-SV), Poster P-07-003 presented at the 4th 2013 European Conference on Schizophrenia Research in Berlin, 26–28 September 2013.
36. Meneghelli A, Alpi A, Casio MT et al. Versione Italiana dell'Early Recognition Inventory for the retrospective assessment of the onset of schizophrenia Checklist: affidabilità, validità e istruzioni per l'uso. J Psychopathol 2014; 20: 186–198.
37. Gaebel W, Buchkremer G, Häfner H et al. 12 Jahre Kompetenznetz Schizophrenie: Ergebnisse und Perspektiven. Fortschr Neurol Psychiatr 2014; 82: 191–202. doi: 10.1055/s-0034-1366193.
38. Wing JK, Cooper JE, Sartorius N. Present state examination (PSE). Medical Research Council/ Cambridge University Press, 1973.
39. Gross G. Bonner Untersuchungsinstrument zur standardisierten Erhebung und Dokumentation von Basissymptomen (BSABS). In: Huber G, ed. Basisstadien endogener Psychosen und das Borderline-Problem. Stuttgart: Schattauer, 1985; 29–46.
40. AMDP – Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie. Das AMDP-System. Manual zur Dokumentation psychischer Befunde, 4th edn. Berlin: Springer, 1983.
41. Maurer K, Trendler G, Schmidt M, an der Heiden W, Könnecke R, Häfner H. Schizophrenie und Depression. Nervenarzt 2006; 77: 809–822.
42. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases – A controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77: 11–24.
43. Häfner H, an der Heiden W. Schizophrenia and depression – challenging the paradigm of two separate diseases. In: Ritsner MS, ed. Handbook of Schizophrenia Spectrum Disorders, Vol. II. Berlin: Springer-Verlag, 2011; 389–402.
44. Häfner H. Schizophrenie und Depression – Zwei eigenständige Erkrankungen? Neuro aktuell 2012; 5: 32–34.
45. Isohanni M, Järvelin M-R, Nieminen P et al. School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the northern Finland 1966 birth cohort. Psychol Med 1998; 28: 967–974.
46. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000; 57: 1053–1058.
47. Krabbendam L, Myin-Germeys I, Hanssen M et al. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol 2005; 44: 113–125.
48. van Rossum I, Dominguez MD, Lieb R, Wittchen HU, van Os J. Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull 2011; 37: 561–571.
49. Klosterkötter J, Hellmich M, Schultze-Lutter F. Ist die Diagnose schizophrener Störungen schon in der initialen Prodromalphase vor der psychotischen Erstmanifestation möglich? Fortschr Neurol Psychiatr 2000; 68 (Sonderheft 1): S13–21.
50. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158–164.
51. Huber G, Gross G, Schüttler R. Schizophrenie. Eine verlaufs- und sozialpsychiatrische Langzeitstudie. Berlin: Springer, 1979.
52. Häfner H, Maurer K. Früherkennung von Psychosen. In: Häfner H, Bechdolf A, Klosterkötter J, Maurer K, eds. Psychosen. Früherkennung und Frühintervention. Der Praxisleitfaden. Stuttgart: Schattauer, 2012; 3–35.
53. Schultze-Lutter F, Ruhrmann S, Picker H et al. Basic symptoms in early psychotic and depressive disorders. Br J Psychiatry 2007; 51 (Suppl.): s31–37.
54. Isohanni M, Rantakallio P, Jones P et al. The predictors of schizophrenia in the 1966 Northern Finland Birth Cohort study. Schizophr Res 1998; 29: 11.
55. Jones P, Done DJ. From birth to onset: a developmental perspective of schizophrenia in two national birth cohorts. In: Keshavan MS, Murray RM, eds. Neurodevelopmental Models of Psychopathology. Cambridge: Cambridge University Press, 1997; 119–136.
56. Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996; 40: 1155–1163.
57. Arsenault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212–1213.
58. Häfner H, Bühler B, Hambrecht M et al. Vorzeitige Auslösung der Psychose durch Substanzmissbrauch und Folgen für den weiteren Verlauf. Nervenheilkunde 2002; 21: 198–207.
59. Van Os J, Verdoux H, Maurice-Tison S. Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 459–463.
60. Van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 2000; 45: 11–20.
61. Van Os J, Linscott R, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009; 39: 179–195.
62. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. Outcome of self-reported psychotic experiences in the general population: a prospective study. In: Hanssen M, ed. A Continuous Psychosis Phenotype: From Description to Prediction. (South-Limburg Mental Health Research and Teaching Network PHD Series). Maastricht: M.S.S. Hanssen, 2004; 95–107.
63. Rausch F, Eifler S, Esser A et al. The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity. Compr Psychiatry 2013; 54: 1068–1076. doi: 10.1016/j.comppsych.2013.04.016 Jun 4.
64. Maurer K, Hörrmann F, Trendler G, Schmidt M, Häfner H. Früherkennung des Psychoserisikos mit dem Early Recognition Inventory (ERIraos). Identification of psychosis risk by the Early Recognition Inventory (ERIraos) – description of the schedules and preliminary results on reliability and validity of the checklist. Nervenheilkunde 2006; 25: 11–16.
65. Häfner H, Bechdolf A, Klosterkötter J, Maurer K. Psychosen. Früherkennung und Frühintervention. Der Praxisleitfaden. Stuttgart: Schattauer, 2012.
66. Raballo A, Meneghelli A, Cocchi A et al. Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2014; 264: 155–169. doi: 10.1007/s00406-013-0421-4.
67. Maurer K, Häfner H. Früherkennung der Schizophrenie und die Bedeutung für Verlauf und Outcome. J Neurol, Neuochir Psychiatr 2007; 8: 24–34.
68. Laier SA. Validierung der ERIraos Checkliste, eines Screeninginstruments zur Früherkennung eines erhöhten Psychoserisikos. Thesis for a masters degree in clinical psychology at the University of Heidelberg in cooperation with the Central Institute of Mental Health, Mannheim, 2008.
69. Maurer K, Häfner H. Rasch scaling of a screening instrument: assessing proximity to psychosis onset by the ERIraos Checklist. Sage open 2014 (Jul 4); 1–10. doi: 10.1177/2158244014545326.
70. Häfner H, Maurer K, Löffler W, Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162: 80–86.
71. Hambrecht M, Häfner H, Löffler W. Beginning schizophrenia observed by significant others. Soc Psychiatry Psychiatr Epidemiol 1994; 29: 53–60.
72. Hambrecht M, Häfner H. Sensitivity and specificity of relatives’ reports on the early course of schizophrenia. Psychopathology 1997; 30: 12–19.
73. Häfner H, an der Heiden W, Maurer K. Evidence for separate diseases? Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci 2008; 258 (Suppl. 2): 85–96.
74. Häfner H, Maurer K, an der Heiden W. The ABC Schizophrenia Study – an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1021–1031. doi: 10.1007/s00127-013-0700-4.
75. Agius M, Goh C, Ulhaq S, McGorry P. The staging model in schizophrenia, and its clinical implications. Psychiatr Danub 2010; 22: 211–220.